amodiaquine has been researched along with Anorexia in 2 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Participants were actively monitored for adverse events for the first 14 days after each treatment, and then passively followed until their next study medication treatment, or withdrawal from study." | 2.73 | Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. ( Clark, TD; Dorsey, G; Jagannathan, P; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, SG; Talisuna, AO; Yau, VM, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mavoko, HM | 1 |
| Nabasumba, C | 1 |
| da Luz, RI | 1 |
| Tinto, H | 1 |
| D'Alessandro, U | 1 |
| Kambugu, A | 1 |
| Baraka, V | 1 |
| Rosanas-Urgell, A | 1 |
| Lutumba, P | 1 |
| Van Geertruyden, JP | 1 |
| Maiteki-Sebuguzi, C | 1 |
| Jagannathan, P | 1 |
| Yau, VM | 1 |
| Clark, TD | 1 |
| Njama-Meya, D | 1 |
| Nzarubara, B | 1 |
| Talisuna, AO | 1 |
| Kamya, MR | 1 |
| Rosenthal, PJ | 1 |
| Dorsey, G | 1 |
| Staedke, SG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Clinical Trial to Measure the Impact of Retreatment With an Artemisinin-based Combination on Malaria Incidence and Its Potential Selection of Resistant Strains[NCT01374581] | Phase 3 | 2,117 participants (Actual) | Interventional | 2012-05-31 | Completed | ||
| Longitudinal Comparison of Combination Antimalarial Therapies in Ugandan Children: Evaluation of Safety, Tolerability, and Efficacy[NCT00123552] | Phase 3 | 601 participants (Actual) | Interventional | 2004-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for amodiaquine and Anorexia
| Article | Year |
|---|---|
Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomise
Topics: Amodiaquine; Anorexia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child | 2017 |
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.
Topics: Amodiaquine; Anorexia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artes | 2008 |